Eli Lilly Covid Antibody Drug Gets Emergency FDA Clearance
Published Date: 11/10/2020
Source: Bloomberg Markets and Finance
Nov.09 -- Pfizer Inc. and BioNTech SE are reporting positive results from their covid-19 vaccine trials, signaling a major breakthrough in the fight to contain the worst outbreak in a century. Meanwhile, Eli Lilly & Co.'s covid-19 antibody therapy has just been granted emergency FDA clearance. Bloomberg’s Michelle Cortez reports on “Bloomberg Daybreak: Asia.”